Zimbabwe has rejected a significant American healthcare agreement valued at $367m (272 million pounds) over five years because of the United States' request for sensitive data.
This rejection was revealed after a official document from December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "skewed".
An official spokesman has since explained that the US was demanding access to health data for scientific study and commercial purposes while was unwilling to guarantee the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for more talks to find a deal suitable to both sides so the country's vital HIV programme can continue.
Broader Context
This development comes after a similar situation in neighbouring Kenya, where a high court halted a similar deal with the US after concerns were raised about the security of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance transparency and accountability.
As per statements, Sixteen African countries have to date signed similar agreements, representing over $18.3bn in new funding.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that provided information," his statement read.
"Put simply, our country would supply the raw materials for medical research without any certainty that the end products would be accessible to our citizens if a new disease outbreak emerge."
Sovereignty and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining systems previously established via the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation provides its information, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to develop them."
These objections over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage further dialogue with our American counterparts on how subsequent co-operation might be arranged in a way that respects the independence and interests of both nations."
Health Experts Response
A leading public health body expressed it understood the official position, but urged that negotiations need to persist since much of the country's HIV programmes were funded by foreign aid.
"Where specific concerns arise, including those relating to information security or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group added.
The halted deal emphasises the continuing tensions between receiving much-needed foreign assistance and protecting a country's data in an ever more data-driven world.